Zentek (CVE:ZEN) Shares Up 41.8% - Should You Buy?

Key Points

• The share price of Zentek Ltd. (CVE:ZEN) surged by 41.8% during trading, reaching a high of C$1.70, before closing at C$1.29.
• Approximately 407,343 shares were traded, marking a significant increase of 752% from the average daily volume.
• Zentek is involved in the research and development of graphene and nanomaterials, producing various products including antimicrobial coatings and surgical masks.

Zentek Ltd. (CVE:ZEN - Get Free Report) shares rose 41.8% during trading on Tuesday . The stock traded as high as C$1.70 and last traded at C$1.29. Approximately 407,343 shares were traded during trading, an increase of 752% from the average daily volume of 47,792 shares. The stock had previously closed at C$0.91.

Zentek Price Performance

The company's fifty day moving average price is C$1.20 and its 200 day moving average price is C$1.57. The company has a market capitalization of C$122.51 million, a P/E ratio of -14.63 and a beta of 0.29. The company has a quick ratio of 7.59, a current ratio of 2.06 and a debt-to-equity ratio of 4.97.

About Zentek

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.